Analysis of the International Cancer Genome Consortium database revealed a prevalence of mutations in epigenetic regulators in CRC, including ATRX, what was mutated in around 7% of samples (Extended Data Fig. 1a). Here, ATRX is linked to colorectal carcinoma.